G1 Therapeutics Operating Margin 2016-2024 | GTHX
Current and historical operating margin for G1 Therapeutics (GTHX) over the last 10 years. The current operating profit margin for G1 Therapeutics as of June 30, 2024 is %.
Operating Margin Historical Data |
Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
2024-06-30 |
$0.06B |
$-0.04B |
-65.52% |
2024-03-31 |
$0.08B |
$-0.02B |
-26.51% |
2023-12-31 |
$0.08B |
$-0.04B |
-47.56% |
2023-09-30 |
$0.08B |
$-0.06B |
-79.22% |
2023-06-30 |
$0.09B |
$-0.07B |
-75.28% |
2023-03-31 |
$0.06B |
$-0.12B |
-200.00% |
2022-12-31 |
$0.05B |
$-0.14B |
-263.46% |
2022-09-30 |
$0.05B |
$-0.14B |
-300.00% |
2022-06-30 |
$0.03B |
$-0.16B |
-562.07% |
2022-03-31 |
$0.03B |
$-0.16B |
-656.00% |
2021-12-31 |
$0.03B |
$-0.14B |
-446.88% |
2021-09-30 |
$0.04B |
$-0.13B |
-300.00% |
2021-06-30 |
$0.07B |
$-0.10B |
-150.77% |
2021-03-31 |
$0.06B |
$-0.09B |
-151.67% |